Compound essential oil for removing stagnated blood and diminishing inflammation
The invention relates to the technical field of beauty and skincare products, and particularly relates to a compound essential oil for removing stagnated blood and diminishing inflammation. The compound essential oil is prepared from the following raw materials in parts by weight in a mixing manner:...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to the technical field of beauty and skincare products, and particularly relates to a compound essential oil for removing stagnated blood and diminishing inflammation. The compound essential oil is prepared from the following raw materials in parts by weight in a mixing manner: 8-10 parts of an angelica sinensis extracting solution, 15-17 parts of a zingiber striolatum diels extracting solution, 8-10 parts of a galium aparine extracting solution, 10-13 parts of rue oil, 5-8 parts of tea tree essential oil, 10-15 parts of tea oil essential oil and 20-30 parts of decocting liquid; and the decocting liquid is decoction which is decocted by 1 part of dandelion, 1 part of taraxacum officnala, 1 part of mother chrysanthemum, 1 part of honeysuckle, 1 part of fructus forsythia, 1 part of cortex albiziae and 1 part of saffron crocus in 5-6fold water at the ratio of 1 to 2.5. Various components in the compound essential oil for removing stagnated blood and diminishing inflammation disclosed by the invention are matched with one another; the tea tree essential oil has the effect of rapidly infiltrating hair follicles; and the effective components such as angelica sinensis, zingiber striolatum diels and galium aparine in the compound essential oil relatively rapidly infiltrate a hypodermic layer, so that the compound essential oil plays roles in promoting blood circulation to remove blood stasis, and circulating channels and collaterals. |
---|